$191.62
▲ +0.4% Today
as of Jul 22, 16:50 ET
Last 30 days
Recent Press Releases & News
mixed
▲ 1
● 24
▼ 0
Eli Lilly (LLY) Joins Illumina Atlas To Map Disease With AI
Illumina (ILMN) Faces German Recall Order Over Element Sequencing Patent Ruling
Illumina expands Billion Cell Atlas program with new AI drug developers
Overview
52-week range
$82
$172
100% of range
Avg surprise (last 2)
+8.9%
Avg reaction (last 1)
+4.2%
100% positive
Latest IV / EM
50%
EM ±11.5% · $190 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Sun Mar 29, 2026 | Mar 2026 | $0.87 | — | — | — | — | financials |
| Sun Sep 28, 2025 | Sep 2025 | $0.98 | — | — | — | — | financials |
| Thu Jul 31, 2025 | Jun/2025 | $1.19 | $1.02 | +16.7% | — | — | earnings |
| Thu May 8, 2025 | Mar/2025 | $0.97 | $0.96 | +1.0% | — | +4.2% | earnings |
| Sun Sep 29, 2024 | Sep 2024 | $4.42 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-12.48 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.79 | — | — | — | — | financials |
| Sun Oct 1, 2023 | Oct 2023 | $-4.77 | — | — | — | — | financials |
| Sun Jul 2, 2023 | Jul 2023 | $-1.48 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Jul 30, 2026 | Jun/2026 | AMC | $1.23 | $1.19 | +3.4% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.09B | — | $1.08B | $1.06B | $1.04B | — | $1.08B | $1.11B |
| Cost of revenue | $370M | — | $351M | $364M | $358M | — | $335M | $391M |
| Gross profit | $721M | — | $733M | $695M | $683M | — | $745M | $721M |
| Operating income | $209M | — | $227M | $214M | $164M | — | $741M | $-1.64B |
| Net income | $134M | $334M | $150M | $235M | $131M | $186M | $705M | $-1.99B |
| EPS (diluted) | $0.87 | — | $0.98 | $1.49 | $0.82 | — | $4.42 | $-12.48 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | — | — | — | — | — | — | — | — |
| Inventory | $611M | $564M | $590M | $575M | $537M | $547M | $574M | $561M |
| Total current assets | $2.74B | $3.29B | $2.80B | $2.64B | $2.67B | $2.75B | $2.37B | $2.46B |
| Total assets | $6.56B | $6.64B | $6.18B | $6.09B | $6.18B | $6.30B | $6.01B | $6.08B |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | — | — | — | — | — | — | — | — |
| Total equity | $2.68B | $2.72B | $2.38B | $2.26B | $2.37B | $2.37B | $2.12B | $1.44B |